Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:08 AM
Study NCT ID:
NCT01514734
Status:
TERMINATED
Last Update Posted:
2013-10-21
First Post:
2012-01-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil
Sponsor:
Alcon Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
None
Primary Completion Date:
2012-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-18
First Submit QC Date:
None
Study First Post Date:
2012-01-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-15
Results First Submit QC Date:
None
Results First Post Date:
2013-10-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-08-15
Last Update Post Date:
2013-10-21
Last Update Post Date Type:
ESTIMATED